Rossari Biotech Limited
Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India.
What Rossari files
- Others55
- Important36
- Investor Meet32
- Board Meeting13
- Updates12
- PPTs9
Rossari Biotech kicked off FY27 with a strong performance, posting consolidated revenue of ₹697.2 Cr, a robust 28.2% YoY jump. Profit after Tax (PAT) edged up 4.5% to ₹35.1 Cr. Key segments like HPPC, TSC, and AHN all delivered impressive YoY growth of 28%, 28%, and 27% respectively, underscoring broad-based...
Here's a concise, retail-friendly summary of Rossari Biotech's Q4 and FY26 investor presentation: **Business Performance:** Rossari Biotech delivered stellar Q4 and FY26 results, reporting its highest-ever quarterly and annual revenue, EBITDA, and PAT. Q4 revenue grew 18.2% YoY to Rs. 684.9 Cr, with full-year FY26 revenue up 15.2% to Rs....
Rossari Biotech delivered a strong Q3 FY26, with consolidated revenue rising 13% YoY to Rs 581.7 Cr. For the nine months, revenue grew 14% YoY to Rs 1,711.5 Cr. While profitability was impacted by strategic investments, Q3 PAT was up 3% YoY to Rs 32.8 Cr, and 9M PAT increased...
Rossari Biotech delivered a strong Q2 FY26! 💪 **Business Performance:** Revenue jumped 18% YoY to Rs 586.1 Cr. EBITDA grew 9% YoY to Rs 71.9 Cr, with Profit After Tax (PAT) up 5% YoY to Rs 36.9 Cr. This robust performance was driven by volume expansion across key segments: HPPC...
Here's a summary of the attached document: **1. Financial Highlights:** Q1 FY26: Rossari Biotech revenue Rs. 543.7 Cr (+11% YoY), EBITDA Rs. 67.9 Cr (+5% YoY, 12.5% margin), PAT Rs. 33.6 Cr (-4% YoY, 6.2% margin). HPPC drove 78% revenue. Core business resilient with ~16% adjusted EBITDA margin. Expect improved...